Global Biobanks Markets Report 2021-2028: Biobanks Continue to Evolve with New Technologies Such as NGS and Increased Focus on Genomic Medicine -…

DUBLIN, March 2, 2021 /PRNewswire/ -- The "Biobanks Market Size, Share & Trends Analysis Report by Product, by Service (Cold Chain, Lab Processing), by Biospecimen Type, by Biobank Type (Virtual, Physical), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global biobanks market size is expected to reach USD 106.9 billion by 2028 and is expected to expand at a CAGR of 6.2% from 2021 to 2028.

Biobanks continue to evolve with the introduction of new technologies such as NGS and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market.

The quality of biospecimens can significantly influence the disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples. For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples.

This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence.

Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

Biobanks Market Report Highlights

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Outlook3.1 Market Dynamics3.1.1 Market driver analysis3.1.1.1 Continuous increase in COVID-19 cases3.1.1.2 Increased focus on precision medicine and genetic testing3.1.1.3 Changes in biobanking operations3.1.1.4 Increase in the number of clinical trials globally3.1.1.5 Growing industry and research collaborations3.1.1.6 Technology advancement and automation3.1.2 Market restraint analysis3.1.2.1 Disruptions in supply chain management due to COVID-193.1.2.2 Challenges in sharing biobanking data & limited access to biospecimens3.1.2.3 Sustainability challenges for biobanks3.1.2.4 Other challenges in biobanking specimens for research3.2 Penetration & Growth Prospect Mapping for Services, 20203.3 Biobanks Market - Regulatory Framework3.3.1 Regulatory Landscape, U.S.3.3.2 Regulatory Landscape, Canada3.3.3 Regulatory Landscape, Europe3.3.4 Regulatory Landscape, China3.3.5 Regulatory Landscape, Japan3.3.6 List of Factors/Regulations/Nature of Governments, by Country3.4 Biobanks Market - Porter's Analysis3.5 Biobanks Market - SWOT Analysis

Chapter 4 Biobanks Market Categorization: Products Estimates & Trend Analysis4.1 Global Biobanks Market: Products Movement Analysis, 2020 & 20284.2 Biobanking Equipment4.2.1 Global biobanking equipment market, 2017 - 2028 (USD Million)4.2.2 Temperature control systems4.2.2.1 Global biobanking temperature control systems market, 2017 - 2028 (USD Million)4.2.2.2 Freezers & refrigerators4.2.2.3 Cryogenic storage systems4.2.2.4 Thawing equipment4.2.3 Incubators & centrifuges4.2.4 Alarms & monitoring systems4.2.5 Accessories & other equipment4.3 Biobanking Consumables4.4 Laboratory Information Management Systems (LIMS)

Chapter 5 Biobanks Market Categorization: Services Estimates & Trend Analysis5.1 Global Biobanks Market: Services Movement Analysis, 2020 & 20285.2 Biobanking & Repository5.3 Lab Processing5.4 Qualification/ Validation5.5 Cold Chain Logistics

Chapter 6 Biobanks Market Categorization: Biospecimen Types Estimates & Trend Analysis6.1 Global Biobanks Market: Biospecimen Types Movement Analysis, 2020 & 20286.2 Human Tissues6.3 Human Organs6.4 Stem Cells6.4.1 Global stem cell biobanking market, 2017 - 2028 (USD Million)6.4.2 Adult stem cells6.4.3 Embryonic stem cells6.4.4 Induced Pluripotent Stem (IPS) Cells6.4.5 Other Stem Cells6.5 Other Biospecimens

Chapter 7 Biobanks Market Categorization: Biobank Types Estimates & Trend Analysis7.1 Global Biobanks Market: Biobank Types Movement Analysis, 2020 & 20287.2 Physical/Real Biobanks7.2.1 Global physical/real biobanks market, 2017 - 2028 (USD Million)7.2.2 Tissue biobanks7.2.3 Population based biobanks7.2.4 Genetic (DNA/RNA) based biobanks7.2.5 Disease based biobanks7.2.6 Global disease based biobanks market, 2017 - 2028 (USD Million)7.3 Virtual Biobanks

Chapter 8 Biobanks Market Categorization: Application Estimates & Trend Analysis8.1 Global Biobanks Market: Application Movement Analysis, 2020 & 20288.2 Therapeutics8.3 Drug Discovery & Clinical Research8.4 Clinical Diagnostics

Chapter 9 Biobanks Market Categorization: Regional Estimates & Trend Analysis, by Products, Services, Biospecimen Types, Biobank Types, & Applications9.1 Biobanks Market Share by Region, 2020 & 2028

Chapter 10 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/3p6obl

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See more here:

Global Biobanks Markets Report 2021-2028: Biobanks Continue to Evolve with New Technologies Such as NGS and Increased Focus on Genomic Medicine -...